+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beta-adrenergic dysfunction exacerbates impairment of working memory induced by hippocampal NMDA receptor blockade in rats



Beta-adrenergic dysfunction exacerbates impairment of working memory induced by hippocampal NMDA receptor blockade in rats



European Journal of Pharmacology 307(1): 21-26



To clarify the interactions between hippocampal glutamatergic and adrenergic systems in the working memory function of rats, the effects of hippocampal NMDA receptor blockade combined with noradrenaline depletion or alpha- and beta-adrenoceptor blockade on this behavior were examined with a three-panel runway task. Intrahippocampal administration of the potent and competitive NMDA receptor antagonist (+/-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) at a dose of 32 ng/side significantly increased the number of errors (attempts to pass through two incorrect panels of the three panels gates at four choice points) in the working memory task, whereas the 3.2 ng/side dose of CPP did not affect working memory errors. Administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2 -bromobenzylamine (DSP-4) at 50 mg/kg i.p. produced marked reductions in hippocampal and cortical noradrenaline contents, but it had no effect on working memory errors. Intrahippocampal administration of 3.2 ng/side CPP, the behaviorally ineffective dose in intact rats, significantly increased the number of working memory errors in the noradrenaline-depleted rats. The alpha-adrenoceptor antagonist phentolamine (3.2 mg/kg i.p.) did not affect working memory errors whether administered alone or in combination with intrahippocampal CPP (3.2 ng/side). The beta-adrenoceptor antagonist propranolol (10 mg/kg i.p.) also had no effect on working memory errors. However, propranolol (10 mg/kg) produced a significant increase in working memory errors when administered together with intrahippocampal CPP (3.2 ng/side). These results suggest that hippocampal NMDA/beta-adrenergic interactions are involved in neural processes mediating working memory function of rats.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008220328

Download citation: RISBibTeXText

PMID: 8831099


Related references

Effects of adrenergic dysfunction in impairment of working memory induced by hippocampal NMDA receptor blockade in rats. Japanese Journal of Pharmacology 71(Suppl. 1): 99P, 1996

Somatostatin alleviates impairment of working memory induced by hippocampal muscarinic M1 receptor blockade in rats. European Journal of Pharmacology 271(2-3): 557-560, 1994

Differential effects of drugs on working memory failure by hippocampal muscarinic and NMDA receptor blockade in rats. Japanese Journal of Pharmacology 73(Suppl. 1): 274P, 1997

Egocentric working memory impairment and dendritic spine plastic changes in prefrontal neurons after NMDA receptor blockade in rats. Brain Research 1402: 101-108, 2011

Concurrent blockade of beta-adrenergic and muscarinic receptors disrupts working memory but not reference memory in rats. Physiology & Behavior 58(2): 307-314, 1995

Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats. Pharmacology Biochemistry & Behavior. 57(1-2): 257-261, 1997

Delay-dependent impairment of spatial working memory with inhibition of NR2B-containing NMDA receptors in hippocampal CA1 region of rats. Molecular Brain 6: 13, 2013

LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment. Experimental Neurology 273: 190-201, 2015

Cholinergic receptor blockade by scopolamine and mecamylamine exacerbates global cerebral ischemia induced memory dysfunction in C57BL/6J mice. Nitric Oxide 43: 62-73, 2014

Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade. Neurobiology of Learning and Memory 72(3): 252-258, 1999

Impairment of working memory by neuronal degeneration with NMDA in rat hippocampal CA-1. Behavioural Pharmacology 3(4): 379-385, 1992

Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats. Life Sciences 67(10): 1139-1147, 2000

Acetylcholine mediates the estrogen-induced increase in hippocampal NMDA receptor binding and the associated enhancement in working memory performance. Society for Neuroscience Abstracts 26(1-2): Abstract No -627 6, 2000

D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats. European Journal Of Pharmacology. 318(2-3): 267-271, 1996

Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia. Hippocampus 5(1): 91-97, 1995